{"schema_version":"secwatch.filing_event.v1","accession":"0001964738-25-000078","form_type":"8-K","ticker":"SOLV","cik":"0001964738","company_name":"Solventum Corp","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.712882+00:00","generated_at":"2026-05-17T09:00:08.811328+00:00","sec_items":["2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Solventum completes $4.0B sale of Purification & Filtration business to Thermo Fisher","bullets":["Completed sale of P&F business to Thermo Fisher for $4.0B cash on September 1, 2025.","Net proceeds of $3.4B primarily to pay down outstanding debt; accelerates debt reduction.","Updated FY2025 guidance: adjusted EPS raised to $5.88-$6.03 from $5.80-$5.95.","Net interest expense now expected at $400M (down from $450M); operating margin toward 20%-21% high-end.","Organic sales growth unchanged at +2.0% to +3.0%; free cash flow maintained at $450M-$550M."],"urls":{"canonical":"https://secwatch.observer/filing/0001964738-25-000078","json":"https://secwatch.observer/filing/0001964738-25-000078.json","markdown":"https://secwatch.observer/filing/0001964738-25-000078.md","text":"https://secwatch.observer/filing/0001964738-25-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000078/0001964738-25-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000078/solv-20250901.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:00:08.811328+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"903ad3b3330a5df430ea76c9666d931ab5f8b474","claim":"Solventum Corp completed a disposition involving Thermo Fisher Scientific Inc. for approximately $4.0 billion (closed 2025-09-01).","evidence_excerpt":"Solventum completed the sale of the Business to the Buyer in accordance with the terms of the Agreement. The cash consideration paid to Solventum at closing was approximately $4.0 billion, which is subject to further adjustments for closing cash and indebtedness, unpaid transaction expenses and working capital as set forth in the Agreement, as well as a payment to","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000078/0001964738-25-000078-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Thermo Fisher Scientific Inc."},{"label":"Consideration","value":"approximately $4.0 billion"},{"label":"Closing","value":"2025-09-01"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}